Meloxicam (Page 8 of 8)

Label Display Panel

//medlibrary.org/lib/images-rx/meloxicam-40/lbl7-5mg100-300x131.jpg
(click image for full-size original)

Package/Label Display Panel

//medlibrary.org/lib/images-rx/meloxicam-40/lbl15mg100-300x130.jpg
(click image for full-size original)
MELOXICAM
meloxicam tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:68462-140
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
MELOXICAM (MELOXICAM) MELOXICAM 7.5 mg
Inactive Ingredients
Ingredient Name Strength
SILICON DIOXIDE
CROSPOVIDONE (120 .MU.M)
LACTOSE MONOHYDRATE
MAGNESIUM STEARATE
MICROCRYSTALLINE CELLULOSE
POVIDONE, UNSPECIFIED
TRISODIUM CITRATE DIHYDRATE
Product Characteristics
Color YELLOW Score no score
Shape ROUND Size 8mm
Flavor Imprint Code 7;5;G14
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:68462-140-01 100 TABLET in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA077932 06/01/2021
MELOXICAM
meloxicam tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:68462-141
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
MELOXICAM (MELOXICAM) MELOXICAM 15 mg
Inactive Ingredients
Ingredient Name Strength
SILICON DIOXIDE
CROSPOVIDONE (120 .MU.M)
LACTOSE MONOHYDRATE
MAGNESIUM STEARATE
MICROCRYSTALLINE CELLULOSE
POVIDONE, UNSPECIFIED
TRISODIUM CITRATE DIHYDRATE
Product Characteristics
Color YELLOW Score no score
Shape OVAL Size 11mm
Flavor Imprint Code 15;G14
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:68462-141-01 100 TABLET in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA077932 06/01/2021
Labeler — Glenmark Pharmaceuticals Inc., USA (130597813)
Establishment
Name Address ID/FEI Operations
Glenmark Pharmaceuticals Limited 677318665 ANALYSIS (68462-140), ANALYSIS (68462-141), MANUFACTURE (68462-140), MANUFACTURE (68462-141)

Revised: 06/2021 Glenmark Pharmaceuticals Inc., USA

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2024. All Rights Reserved.